Your browser doesn't support javascript.
loading
Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendations.
Pasté, Muriel; Stoffel, Michel; Bardone, Corinne; Baron-Papillon, Florence; Czwarno, Anna; Galbraith, Heike; Gastineau, Thierry; Germay, Olivier; Gonzo, Davide; Juvin, Philippe; Kissane, Julia; Laigle, Valérie; Mlynarczyk, Peter; van Hoof, Paul; Wettendorff, Martine; Quilici, Sibilia.
Afiliação
  • Pasté M; Development of this publication; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium. Electronic address: muriel.m.paste@gsk.com.
  • Stoffel M; Development of this publication; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium. Electronic address: michel.stoffel@gsk.com.
  • Bardone C; Sanofi Pasteur, Campus Sanofi Lyon Carteret, 14 espace Henry Vallée 69007 Lyon, France. Electronic address: Corinne.Bardone@sanofi.com.
  • Baron-Papillon F; Sanofi Pasteur, Campus Sanofi Lyon Carteret, 14 espace Henry Vallée 69007 Lyon, France. Electronic address: Florence.BaronPapillon@sanofi.com.
  • Czwarno A; Vaccine Europe, Leopold Plaza Building, Rue du Trône 108, 1050 Brussels, Belgium. Electronic address: anna.czwarno@vaccineseurope.eu.
  • Galbraith H; Pfizer, Belgium, Boulevard de la Plaine 17, 1050 Ixelles, Belgium. Electronic address: Heike.Galbraith@pfizer.com.
  • Gastineau T; Sanofi Pasteur, Campus Sanofi Lyon Carteret, 14 espace Henry Vallée 69007 Lyon, France. Electronic address: Thierry.Gastineau@sanofi.com.
  • Germay O; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium. Electronic address: olivier.c.germay@gsk.com.
  • Gonzo D; MSD, Weystrasse 20, 8006 Lucerne, Switzerland. Electronic address: davide.gonzo@merck.com.
  • Juvin P; Sanofi Pasteur, Campus Sanofi Lyon Carteret, 14 espace Henry Vallée 69007 Lyon, France. Electronic address: paul.l.van-hoof@gsk.com.
  • Kissane J; Pfizer, 32 New Lane, Havant, PO9 2NG, UK. Electronic address: Julia.Kissane@pfizer.com.
  • Laigle V; MSD Vaccins, 162 Avenue Jean Jaures, 69007 Lyon, France. Electronic address: Valerie.laigle@msd.com.
  • Mlynarczyk P; MSD, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, USA. Electronic address: peter_mlynarczyk@merck.com.
  • van Hoof P; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium.
  • Wettendorff M; GlaxoSmithKline Biologicals, Avenue Fleming, 20, 1300 Wavre, Belgium. Electronic address: martine.wettendorff@gsk.com.
  • Quilici S; Vaccine Europe, Leopold Plaza Building, Rue du Trône 108, 1050 Brussels, Belgium. Electronic address: sibilia.quilici@vaccineseurope.eu.
Health Policy ; 126(1): 35-42, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34887101
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Health Policy Assunto da revista: PESQUISA EM SERVICOS DE SAUDE / SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Health Policy Assunto da revista: PESQUISA EM SERVICOS DE SAUDE / SAUDE PUBLICA Ano de publicação: 2022 Tipo de documento: Article